A Multi-arm Phase 1b Study of Talquetamab With Other Anticancer Therapies in Participants with Multiple Myeloma

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503620-60-00

Acronym

64407564MMY1004

Enrollment

Registered

2024-05-08

Start date

2021-12-22

Completion date

Unknown

Last updated

2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026